Skip to main content
Download PDF

The CAFA challenge reports improved protein function prediction and new functional annotations for hundreds of genes through experimental screens

Genome Biology volume 20, Article number: 244 (2019) Cite this article

Abstract

Background

The Critical Assessment of Functional Annotation (CAFA) is an ongoing, global, community-driven effort to evaluate and improve the computational annotation of protein function.

Results

Here, we report on the results of the third CAFA challenge, CAFA3, that featured an expanded analysis over the previous CAFA rounds, both in terms of volume of data analyzed and the types of analysis performed. In a novel and major new development, computational predictions and assessment goals drove some of the experimental assays, resulting in new functional annotations for more than 1000 genes. Specifically, we performed experimental whole-genome mutation screening in Candida albicans and Pseudomonas aureginosa genomes, which provided us with genome-wide experimental data for genes associated with biofilm formation and motility. We further performed targeted assays on selected genes in Drosophila melanogaster, which we suspected of being involved in long-term memory.

Conclusion

We conclude that while predictions of the molecular function and biological process annotations have slightly improved over time, those of the cellular component have not. Term-centric prediction of experimental annotations remains equally challenging; although the performance of the top methods is significantly better than the expectations set by baseline methods in C. albicans and D. melanogaster, it leaves considerable room and need for improvement. Finally, we report that the CAFA community now involves a broad range of participants with expertise in bioinformatics, biological experimentation, biocuration, and bio-ontologies, working together to improve functional annotation, computational function prediction, and our ability to manage big data in the era of large experimental screens.

Introduction

High-throughput nucleic acid sequencing [1] and mass-spectrometry proteomics [2] have provided us with a deluge of data for DNA, RNA, and proteins in diverse species. However, extracting detailed functional information from such data remains one of the recalcitrant challenges in the life sciences and biomedicine. Low-throughput biological experiments often provide highly informative empirical data related to various functional aspects of a gene product, but these experiments are limited by time and cost. At the same time, high-throughput experiments, while providing large amounts of data, often provide information that is not specific enough to be useful [3]. For these reasons, it is important to explore computational strategies for transferring functional information from the group of functionally characterized macromolecules to others that have not been studied for particular activities [4–9].

To address the growing gap between high-throughput data and deep biological insight, a variety of computational methods that predict protein function have been developed over the years [10–24]. This explosion in the number of methods is accompanied by the need to understand how well they perform, and what improvements are needed to satisfy the needs of the life sciences community. The Critical Assessment of Functional Annotation (CAFA) is a community challenge that seeks to bridge the gap between the ever-expanding pool of molecular data and the limited resources available to understand protein function [25–27].

The first two CAFA challenges were carried out in 2010–2011 [25] and 2013–2014 [26]. In CAFA1, we adopted a time-delayed evaluation method, where protein sequences that lacked experimentally verified annotations, or targets, were released for prediction. After the submission deadline for predictions, a subset of these targets accumulated experimental annotations over time, either as a consequence of new publications about these proteins or the biocuration work updating the annotation databases. The members of this set of proteins were used as benchmarks for evaluating the participating computational methods, as the function was revealed only after the prediction deadline.

CAFA2 expanded the challenge founded in CAFA1. The expansion included the number of ontologies used for predictions, the number of target and benchmark proteins, and the introduction of new assessment metrics that mitigate the problems with functional similarity calculation over concept hierarchies such as Gene Ontology [28]. Importantly, we provided evidence that the top-scoring methods in CAFA2 outperformed the top-scoring methods in CAFA1, highlighting that methods participating in CAFA improved over the 3-year period. Much of this improvement came as a consequence of novel methodologies with some effect of the expanded annotation databases [26]. Both CAFA1 and CAFA2 have shown that computational methods designed to perform function prediction outperform a conventional function transfer through sequence similarity [25, 26].

In CAFA3 (2016–2017), we continued with all types of evaluations from the first 2 challenges and additionally performed experimental screens to identify genes associated with specific functions. This allowed us to provide unbiased evaluation of the term-centric performance based on a unique set of benchmarks obtained by assaying Candida albicans, Pseudomonas aeruginosa, and Drosophila melanogaster. We also held a challenge following CAFA3, dubbed CAFA- π, to provide the participating teams another opportunity to develop or modify prediction models. The genome-wide screens on C. albicans identified 240 genes previously not known to be involved in biofilm formation, whereas the screens on P. aeruginosa identified 532 new genes involved in biofilm formation and 403 genes involved in motility. Finally, we used CAFA predictions to select genes from D. melanogaster and assay them for long-term memory involvement. This experiment allowed us to both evaluate prediction methods and identify 11 new fly genes involved in this biological process [29]. Here, we present the outcomes of the CAFA3 challenge, as well as the accompanying challenge CAFA- π, and discuss further directions for the community interested in the function of biological macromolecules.

Results

Top methods have improved from CAFA2 to CAFA3, but improvement was less dramatic than from CAFA1 to CAFA2

One of CAFA’s major goals is to quantify the progress in function prediction over time. We therefore conducted a comparative evaluation of top CAFA1, CAFA2, and CAFA3 methods according to their ability to predict Gene Ontology [28] terms on a set of common benchmark proteins. This benchmark set was created as an intersection of CAFA3 benchmarks (proteins that gained experimental annotation after the CAFA3 prediction submission deadline) and CAFA1 and CAFA2 target proteins. Overall, this set contained 377 protein sequences with annotations in the Molecular Function Ontology (MFO), 717 sequences in the Biological Process Ontology (BPO), and 548 sequences in the Cellular Component Ontology (CCO), which allowed for a direct comparison of all methods that have participated in the challenges so far. The head-to-head comparisons in MFO, BPO, and CCO between the top 5 CAFA3 and CAFA2 methods are shown in Fig. 1. CAFA3 and CAFA1 comparisons are shown in Additional file 1: Figure S1.

Fig. 1
figure1

A comparison in Fmax between the top 5 CAFA2 models against the top 5 CAFA3 models. Colored boxes encode the results such that (1) the colors indicate margins of a CAFA3 method over a CAFA2 method in Fmax and (2) the numbers in the box indicate the percentage of wins. a CAFA2 top 5 models (rows, from top to bottom) against CAFA3 top 5 models (columns, from left to right). b Comparison of the performance (Fmax) of Naïve baselines trained respectively on SwissProt2014 and SwissProt2017. Colored box between the two bars shows the percentage of wins and margin of wins as in a. c Comparison of the performance (Fmax) of BLAST baselines trained on SwissProt2014 and SwissProt2017. Colored box between the two bars shows the percentage of wins and margin of wins as in a. Statistical significance was assessed using 10,000 bootstrap samples of benchmark proteins

Full size image

We first observe that, in effect, the performance of baseline methods [25, 26] has not improved since CAFA2. The Naïve method, which uses the term frequency in the existing annotation database as a prediction score for every input protein, has the same Fmax performance using both annotation databases in 2014 (when CAFA2 was held) and in 2017 (when CAFA3 was held), which suggests little change in term frequencies in the annotation database since 2014. In MFO, the BLAST method based on the existing annotations in 2017 is slightly but significantly better than the BLAST method based on 2014 training data. In BPO and CCO, however, the BLAST based on the later database has not outperformed its earlier counterpart, although the changes in effect size (absolute change in Fmax) in both ontologies are small.

When surveying all 3 CAFA challenges, the performance of both baseline methods has been relatively stable, with some fluctuations of BLAST. Such performance of direct sequence-based function transfer is surprising, given the steady growth of annotations in UniProt-GOA [30]; that is, there were 259,785 experimental annotations in 2011, 341,938 in 2014, and 434,973 in 2017, but there does not seem to be a definitive trend with the BLAST method, as they go up and down in Fmax across ontologies. We conclude from these observations on the baseline methods that first, the ontologies are in different annotation states and should not be treated as a whole. In fact, the distribution of annotation depth and information content is very different across 3 ontologies, as shown in Additional file 1: Figures S15 and S16. Second, methods that perform direct function transfer based on sequence similarity do not necessarily benefit from a larger training dataset. Although the performance observed in our work is also dependent on the benchmark set, it appears that the annotation databases remain too sparsely populated to effectively exploit function transfer by sequence similarity, thus justifying the need for advanced methodology development for this problem.

Head-to-head comparisons of the top 5 CAFA3 methods against the top 5 CAFA2 methods show mixed results. In MFO, the top CAFA3 method, GOLabeler [23], outperformed all CAFA2 methods by a considerable margin, as shown in Fig. 2. The rest of the 4 CAFA3 top methods did not perform as well as the top 2 methods of CAFA2, although only to a limited extent, with little change in Fmax. Of the top 12 methods ranked in MFO, 7 are from CAFA3, 5 are from CAFA2, and none from CAFA1. Despite the increase in database size, the majority of function prediction methods do not seem to have improved in predicting protein function in MFO since 2014, except for 1 method that stood out. In BPO, the top 3 methods in CAFA3 outperformed their CAFA2 counterparts, but with very small margins. Out of the top 12 methods in BPO, 8 are from CAFA3, 4 are from CAFA2, and none from CAFA1. Finally, in CCO, although 8 out of the top 12 methods over all CAFA challenges come from CAFA3, the top method is from CAFA2. The differences between the top-performing methods are small, as in the case of BPO.

Fig. 2
figure2

Performance evaluation based on the Fmax for the top CAFA1, CAFA2, and CAFA3 methods. The top 12 methods are shown in this barplot ranked in descending order from left to right. The baseline methods are appended to the right; they were trained on training data from 2017, 2014, and 2011, respectively. Coverage of the methods were shown as text inside the bars. Coverage is defined as the percentage of proteins in the benchmark that are predicted by the methods. Color scheme: CAFA2, ivory; CAFA3, green; Naïve, red; BLAST, blue. Note that in MFO and BPO, CAFA1 methods were ranked, but since none made to the top 12 of all 3 CAFA challenges, they were not displayed. The CAFA1 challenge did not collect predictions for CCO. a: molecular function; b: Biological process; c: Cellular Component

Full size image

The performance of the top methods in CAFA2 was significantly better than of those in CAFA1, and it is interesting to note that this trend has not continued in CAFA3. This could be due to many reasons, such as the quality of the benchmark sets, the overall quality of the annotation database, the quality of ontologies, or a relatively short period of time between challenges.

Protein-centric evaluation

The protein-centric evaluation measures the accuracy of assigning GO terms to a protein. This performance is shown in Figs. 3 and 4.

Fig. 3
figure3

Performance evaluation based on the Fmax for the top-performing methods in 3 ontologies. Evaluation was carried out on No knowledge benchmarks in the full mode. a–c: bar plots showing the Fmax of the top 10 methods. The 95% confidence interval was estimated using 10,000 bootstrap iterations on the benchmark set. Coverage of the methods was shown as text inside the bars. Coverage is defined as the percentage of proteins in the benchmark which are predicted by the methods. d–f: precision-recall curves for the top 10 methods. The perfect prediction should have Fmax=1, at the top right corner of the plot. The dot on the curve indicates where the maximum F score is achieved

Full size image
Fig. 4
figure4

Performance evaluation based on Smin for the top-performing methods in 3 ontologies. Evaluation was carried out on No knowledge benchmarks in the full mode. a–c: bar plots showing Smin of the top 10 methods. The 95% confidence interval was estimated using 10,000 bootstrap iterations on the benchmark set. Coverage of the methods was shown as text inside the bars. Coverage is defined as the percentage of proteins in the benchmark which are predicted by the methods. d–f: remaining uncertainty-missing information (RU-MI) curves for the top 10 methods. The perfect prediction should have Smin=0, at the bottom left corner of the plot. The dot on the curve indicates where the minimum semantic distance is achieved

Full size image

We observe that all top methods outperform the baselines with the patterns of performance consistent with CAFA1 and CAFA2 findings. Predictions of MFO terms achieved the highest Fmax compared with predictions in the other two ontologies. BLAST outperforms Naïve in predictions in MFO, but not in BPO or CCO. This is because sequence similarity-based methods such as BLAST tend to perform best when transferring basic biochemical annotations such as enzymatic activity. Functions in biological process, such as pathways, may not be as preserved by sequence similarity, hence the poor BLAST performance in BPO. The reasons behind the difference among the three ontologies include the structure and complexity of the ontology as well as the state of the annotation database, as discussed previously [26, 31]. It is less clear why the performance in CCO is weak, although it might be hypothesized that such performance is related to the structure of the ontology itself [31].

The top-performing method in MFO did not have as high an advantage over others when evaluated using the Smin metric. The Smin metric weights GO terms by conditional information content, since the prediction of more informative terms is more desirable than less informative, more general, terms. This could potentially explain the smaller gap between the top predictor and the rest of the pack in Smin. The weighted Fmax and normalized Smin evaluations can be found in Additional file 1: Figures S4 and S5.

Species-specific categories

The benchmarks in each species were evaluated individually as long as there were at least 15 proteins per species. Here, we present the results from eukaryotic and bacterial species (Fig. 5). We observed that different methods could perform differently on different species. As shown in Fig. 6, bacterial proteins make up a small portion of all benchmark sequences, so their effects on the performances of the methods are often masked. Species-specific analyses are therefore useful to researchers studying certain organisms. Evaluation results on individual species including human (Additional file 1: Figure S6), Arabidopsis thaliana (Additional file 1: Figure S7) and Escherichia coli (Additional file 1: Figure S10) can be found in Additional file 1: Figure S6-S14.

Fig. 5
figure5

Evaluation based on the Fmax for the top-performing methods in eukaryotic and bacterial species

Full size image
Fig. 6
figure6

Number of proteins in each benchmark species and ontology

Full size image

Diversity of methods

It was suggested in the analysis of CAFA2 that ensemble methods that integrate data from different sources have the potential of improving prediction accuracy [32]. Multiple data sources, including sequence, structure, expression profile, genomic context, and molecular interaction data, are all potentially predictive of the function of the protein. Therefore, methods that take advantage of these rich sources as well as existing techniques from other research groups might see improved performance. Indeed, the one method that stood out from the rest in CAFA3 and performed significantly better than all methods across three challenges is a machine learning-based ensemble method [23]. Therefore, it is important to analyze what information sources and prediction algorithms are better at predicting function. Moreover, the similarity of the methods might explain the limited improvement in the rest of the methods in CAFA3.

The top CAFA2 and CAFA3 methods are very similar in performance, but that could be a result of aggregating predictions of different proteins to one metric. When computing the similarity of each pair of methods as the Euclidean distance of prediction scores (Fig. 7), we are not interested whether these predictions are correct according to the benchmarks, but simply whether they are similar to one another. The diagonal blocks in Fig. 7 show that CAFA1 top methods are more diverse than CAFA2 and CAFA3. The off-diagonal blocks shows that CAFA2 and CAFA3 methods are more similar with each other than with CAFA3 methods. It is clear that some methods are heavily based on the Naïve and BLAST baseline methods.

Fig. 7
figure7

Heatmap of similarity for the top 10 methods in CAFA1, CAFA2, and CAFA3. Similarity is represented by Euclidean distance of the prediction scores from each pair of methods, using the intersection set of benchmarks in the “Top methods have improved from CAFA2 to CAFA3, but improvement was less dramatic than from CAFA1 to CAFA2” section. The higher (darker red color) the euclidean distance, the less similar the methods are. Top 10 methods from each of the CAFA challenges are displayed and ranked by their performance in Fmax. Cells highlighted by black borders are between a pair of methods that come from the same PI. a: Molecular Function; b: Biological Process; c: Cellular Component

Full size image

Participating teams also provided keywords that describe their approach to function prediction with their submissions. A list of keywords was given to the participants, listed in Additional file 1. Figure 8 shows the frequency of each keyword. In addition, we have weighted the frequency of the keywords with the prediction accuracy of the specific method. Machine learning and sequence alignment remain the most used approach by scientists predicting in all three ontologies. By raw count, machine learning is more popular than sequence in all three ontologies, but once adjusted by performance, their difference shrinks. In MFO, sequence alignment even overtakes machine learning as the most popular keyword after adjusting for performance. This indicates that methods that use sequence alignments are more helpful in predicting the correct function than the popularity of their use suggests.

Fig. 8
figure8

Keyword analysis of all CAFA3 participating methods. a–c: both relative frequency of the keywords and weighted frequencies are provided for three respective GO ontologies. The weighted frequencies accounts for the performance of the the particular model using the given keyword. If that model performs well (with high Fmax), then it gives more weight to the calculation of the total weighted average of that keyword. d shows the ratio of relative frequency between the Fmax-weighted and equal-weighted. Red indicates the ratio is greater than one while blue indicates the ratio is less than one. Only the top five keywords ranked by ratio are shown. The larger the ratio, the more difference there is between the Fmax-weighted and the equal-weighted

Full size image

Evaluation via molecular screening

Databases with proteins annotated by biocuration, such as UniProt knowledge base and UniProt Gene Ontology Annotation (GOA) database, have been the primary source of benchmarks in the CAFA challenges. New to CAFA3, we also evaluated the extent to which methods participating in CAFA could predict the results of genetic screens in model organisms done specifically for this project. Predicting GO terms for a protein (protein-centric) and predicting which proteins are associated with a given function (term-centric) are related but different computational problems: the former is a multi-label classification problem with a structured output, while the latter is a binary classification task. Predicting the results of a genome-wide screen for a single or a small number of functions fits the term-centric formulation. To see how well all participating CAFA methods perform term-centric predictions, we mapped the results from the protein-centric CAFA3 methods onto these terms. In addition, we held a separate CAFA challenge, CAFA- π, whose purpose was to attract additional submissions from algorithms that specialize in term-centric tasks.

We performed screens for three functions in three species, which we then used to assess protein function prediction. In the bacterium Pseudomonas aeruginosa and the fungus Candida albicans, we performed genome-wide screens capable of uncovering genes with two functions, biofilm formation (GO:0042710) and motility (for P. aeruginosa only) (GO:0001539), as described in the “Methods” section. In Drosophila melanogaster, we performed targeted assays, guided by previous CAFA submissions, of a selected set of genes and assessed whether or not they affected long-term memory (GO:0007616).

We discuss the prediction results for each function below in detail. The performance, as assessed by the genome-wide screens, was generally lower than in the protein-centric evaluations that were curation driven. We hypothesize that it may simply be more difficult to perform term-centric prediction for broad activities such as biofilm formation and motility. For P. aeruginosa, an existing compendium of gene expression data was already available [33]. We used the Pearson correlation over this collection of data to provide a complementary baseline to the standard BLAST approach used throughout CAFA. We found that an expression-based method outperformed the CAFA participants, suggesting that success on certain term-centric challenges will require the use of different types of data. On the other hand, the performance of the methods in predicting long-term memory in the Drosophila genome was relatively accurate.

Biofilm formation

In March 2018, there were 3019 annotations to biofilm formation (GO:0042710) and its descendent terms across all species, of which 325 used experimental evidence codes. These experimentally annotated proteins included 131 from the Candida Genome Database [34] for C. albicans and 29 for P. aeruginosa, the 2 organisms that we screened.

Of the 2746 genes we screened in the Candida albicans colony biofilm assay, 245 were required for the formation of wrinkled colony biofilm formation (Table 1). Of these, only 5 were already annotated in UniProt: MOB, EED1 (DEF1), and YAK1, which encode proteins involved in hyphal growth, an important trait for biofilm formation [35–38]. Also, NUP85, a nuclear pore protein involved in early phase arrest of biofilm formation [39] and VPS1, contributes to protease secretion, filamentation, and biofilm formation [40]. Of the 2063 proteins that we did not find to be associated with biofilm formation, 29 were annotated with the term in the GOA database in C. albicans. Some of the proteins in this category highlight the need for additional information to GO term annotation. For example, Wor1 and the pheromone receptor are key for biofilm formation in strains under conditions in which the mating pheromone is produced [41], but not required in the monocultures of the commonly studied a/ α mating type strain used here.

Table 1 Number of proteins in Candida albicans and Pseudomonas aeruginosa associated with the GO term “Biofilm formation” (GO:0042710) in the GOA databases versus experimental results
Full size table

We used receiver operating characteristic (ROC) curves to measure the prediction accuracy. Area under ROC curves (AUROC) was used to compare the performance. AUROC is a common accuracy measure for classification problems where it evaluates how good a model is at distinguishing between the positive and negative classes. No method in CAFA- π or CAFA3 (not shown) exceeded an AUC of 0.60 on this term-centric challenge (Fig. 9) for either species. Performance for the best methods slightly exceeded a BLAST-based baselines. In the past, we have found that predicting BPO terms, such as biofilm formation, resulted in poorer method performance than predicting MFO terms. Many CAFA methods use sequence alignment as their primary source of information (the “Diversity of methods” section). For Pseudomonas aeruginosa, a pre-built expression compendium was available from prior work [33]. Where the compendium was available, simple gene expression-based baselines were the best-performing approaches. This suggests that successful term-centric prediction of biological processes may need to rely more heavily on information that is not sequence-based and, as previously reported, may require methods that use broad collections of gene expression data [42, 43].

Fig. 9
figure9

AUROC of the top five teams in CAFA- π. The best-performing model from each team is picked for the top five teams, regardless of whether that model is submitted as model 1. Four baseline models all based on BLAST were computed for Candida, while six baseline models were computed for Pseudomonas, including two based on expression profiles. All team methods are in gray while BLAST methods are in red, BLAST computational methods are in blue, and expression are in yellow, see Table 3 for the description of the baselines

Full size image

Motility

In March 2018, there were 302,121 annotations for proteins with the GO term: cilium or flagellum-dependent cell motility (GO:0001539) and its descendent terms, which included cell motility in all eukaryotic (GO:0060285), bacterial (GO:0071973), and archaeal (GO:0097590) organisms. Of these, 187 had experimental evidence codes, and the most common organism to have annotations was P. aeruginosa, on which our screen was performed (Additional file 1: Table S2).

As expected, mutants defective in the flagellum or its motor were defective in motility (fliC and other fli and flg genes). For some of the genes that were expected, but not detected, the annotation was based on the experiments performed in a medium different from what was used in these assays. For example, PhoB regulates motility but only when phosphate concentration is low [44]. Among the genes that were scored as defective in motility, some are known to have decreased motility due to over production of carbohydrate matrix material (bifA) [45], or the absence of directional swimming due to absence of chemotaxis functions (e.g., cheW, cheA) and others likely showed this phenotype because of a medium-specific requirement such as biotin (bioA, bioC, and bioD) [46]. Table 2 shows the contingency table for the number of proteins that are detected by our experiment versus GOA annotations.

Table 2 Number of proteins in Pseudomonas aeruginosa associated with function motility (GO:0001539) in the GOA databases versus experimental results
Full size table

The results from this evaluation were consistent with what we observed for biofilm formation. Many of the genes annotated as being involved in biofilm formation were identified in the screen. Others that were annotated as being involved in biofilm formation did not show up in the screen because the strain background used here, strain PA14, uses the exopolysaccharide matrix carbohydrate Pel [47] in contrast to the Psl carbohydrate used by another well-characterized strain, strain PAO1 [48, 49]. The psl genes were known to be dispensable for biofilm formation in the strain PA14 background, and this nuance highlights the need for more information to be taken into account when making predictions.

The CAFA- π methods outperformed our BLAST-based baselines but failed to outperform the expression-based baselines. Transferred methods from CAFA3 also did not outperform these baselines. It is important to note this consistency across terms, reinforcing the finding that term-centric prediction of biological processes is likely to require non-sequence information to be included.

Long-term memory in D. melanogaster

Prior to our experiments, there were 1901 annotations made in the long-term memory, including 283 experimental annotations. Drosophila melanogaster had the most annotated proteins of long-term memory with 217, while human has 7, as shown in Additional file 1: Table S3.

We performed RNAi experiments in Drosophila melanogaster to assess whether 29 target genes were associated with long-term memory (GO:0007616). Briefly, flies were exposed to wasps, which triggers a behavior that causes females to lay fewer eggs. The acute response is measured until 24 h post-exposure, and the long-term response is measured at 24 to 48 h post-exposure. RNAi was used to interfere with the expression of the 29 target genes in the mushroom body, a region of the fly brain associated with memory. Using this assay, we identified 3 genes involved in the perception of wasp exposure and 12 genes involved in the long-term memory. For details on the target selection and fly assay, see [29]. None of the 29 genes had an existing annotation in the GOA database. Because no genome-wide screen results were available, we did not release this as part of the CAFA- π and instead relied only on the transfer of methods that predicted the “long-term memory" at least once in D. melanogaster from CAFA3. Results from this assessment were more promising than our findings from the genome-wide screens in microbes (Fig. 10). Certain methods performed well, substantially exceeding the baselines.

Fig. 10
figure10

AUROC of top five teams in CAFA3. The best-performing model from each team is picked for the top five teams, regardless of whether that model is submitted as model 1. All team methods are in gray while BLAST methods are in red and BLAST computational methods are in blue, see Table 3 for the description of the baselines

Full size image
Table 3 Baseline methods in term-centric evaluation of protein function prediction
Full size table

Participation growth

The CAFA challenge has seen growth in participation, as shown in Fig. 11. To cope with the increasingly large data size, CAFA3 utilized the Synapse [50] online platform for submission. Synapse allowed for easier access for participants, as well as easier data collection for the organizers. The results were also released to the individual teams via this online platform. During the submission process, the online platform also allows for customized format checkers to ensure the quality of the submission.

Fig. 11
figure11

CAFA participation has been growing. Each principal investigator is allowed to head multiple teams, but each member can only belong to one team. Each team can submit up to three models

Full size image

Methods

Benchmark collection

In CAFA3, we adopted the same benchmark generation methods as CAFA1 and CAFA2, with a similar timeline (Fig. 12). The crux of a time-delayed challenge is the annotation growth period between time t0 and t1. All target proteins that have gained experimental annotation during this period are taken as benchmarks in all three ontologies. “No knowledge” (NK, no prior experimental annotations) and “Limited knowledge” (LK, partial prior experimental annotations) benchmarks were also distinguished based on whether the newly gained experimental annotation is in an ontology that already have experimental annotations or not. Evaluation results in Figs. 3 and 4 are made using the No knowledge benchmarks. Evaluation results on the Limited knowledge benchmarks are shown in Additional file 1: Figure S3. For more information regarding NK and LK designations, please refer to the Additional file 1 and the CAFA2 paper [26].

Fig. 12
figure12

CAFA3 timeline

Full size image

After collecting these benchmarks, we performed two major deletions from the benchmark data. Upon inspecting the taxonomic distribution of the benchmarks, we noticed a large number of new experimental annotations from Candida albicans. After consulting with UniProt-GOA, we determined these annotations have already existed in the Candida Genome Database long before 2018 but were only recently migrated to GOA. Since these annotations were already in the public domain before the CAFA3 submission deadline, we have deleted any annotation from Candida albicans with an assigned date prior to our CAFA3 submission deadline. Another major change is the deletion of any proteins with only a protein-binding (GO:0005515) annotation. Protein binding is a highly generalized function description, does not provide more specific information about the actual function of a protein, and in many cases may indicate a non-functional, non-specific binding. If it is the only annotation that a protein has gained, then it is hardly an advance in our understanding of that protein; therefore, we deleted these annotations from our benchmark set. Annotations with a depth of 3 make up almost half of all annotations in MFO before the removal (Additional file 1: Figure S15B). After the removal, the most frequent annotations became of depth 5 (Additional file 1: Figure S15A). In BPO, the most frequent annotations are of depth 5 or more, indicating a healthy increase of specific GO terms being added to our annotation database. In CCO, however, most new annotations in our benchmark set are of depths 3, 4, and 5 (Additional file 1: Figure S15). This difference could partially explain why the same computational methods perform very differently in different ontologies and benchmark sets. We have also calculated the total information content per protein for the benchmark sets shown in Additional file 1: Figure S16. Taxonomic distributions of the proteins in our final benchmark set are shown in Fig. 6.

Additional analyses were performed to assess the characteristics of the benchmark set, including the overall information content of the terms being annotated.

Protein-centric evaluation

Two main evaluation metrics were used in CAFA3, the Fmax and the Smin. The Fmax based on the precision-recall curve (Fig. 3), while the Smin is based on the remaining uncertainty/missing information (RU-MI) curve as described in [51] (Fig. 4), where S stands for semantic distance. The shortest semantic distance across all thresholds is used as the Smin metric. The RU-MI curve takes into account the information content of each GO term in addition to counting the number of true positives, false positives, etc., see Additional file 1 for the precise definition of Fmax and Smin. The information theory-based evaluation metrics counter the high-throughput low-information annotations such as protein binding, but down-weighing these terms according to their information content, as the ability to predict such non-specific functions are not as desirable and useful and the ability to predict more specific functions.

The two assessment modes from CAFA2 were also used in CAFA3. In the partial mode, predictions were evaluated only on those benchmarks for which a model made at least one prediction. The full evaluation mode evaluates all benchmark proteins, and methods were penalized for not making predictions. Evaluation results in Figs. 3 and 4 are made using the full evaluation mode. Evaluation results using the partial mode are shown in Additional file 1: Figure S2.

Two baseline models were also computed for these evaluations. The Naïve method assigns the term frequency as the prediction score for any protein, regardless of any protein-specific properties. BLAST was based on the results using the Basic Local Alignment Search Tool (BLAST) software against the training database [52]. A term will be predicted as the highest local alignment sequence identity among all BLAST hits annotated from the training database. Both of these methods were trained on the experimentally annotated proteins and their sequences in Swiss-Prot [53] at time t0.

Microbe screens

To assess the matrix production, we used mutants from the PA14 NR collection [54]. Mutants were transferred from the − 80 ∘C freezer stock using a sterile 48-pin multiprong device into 200 µl LB in a 96-well plate. The cultures were incubated overnight at 37 ∘C, and their OD600 was measured to assess growth. Mutants were then transferred to tryptone agar with 15 g of tryptone and 15 g of agar in 1L amended with Congo red (Aldrich, 860956) and Coomassie brilliant blue (J.T. Baker Chemical Co., F789-3). Plates were incubated at 37 ∘C overnight followed by 4-day incubation at room temperature to allow the wrinkly phenotype to develop. Colonies were imaged and scored on day 5. To assess motility, mutants were revived from freezer stocks as described above. After overnight growth, a sterile 48-pin multiprong transfer device with a pin diameter of 1.58 mm was used to stamp the mutants from the overnight plates into the center of swim agar made with M63 medium with 0.2% glucose and casamino acids and 0.3% agar). Care was taken to avoid touching the bottom of the plate. Swim plates were incubated at room temperature (19–22 ∘C) for approximately 17 h before imaging and scoring. Experimental procedures in P. aeruginosa to determine proteins that are associated with the two functions in CAFA- π are shown in Fig. 13.

Fig. 13
figure13

Experimental procedure of determining genes associated with the functions biofilm formation (a) and motility (b) in P. aeruginosa

Full size image

Biofilm formation in Candida albicans was assessed in single gene mutants from the Noble [55] and GRACE [56] collections. In the Noble Collection, mutants of C. albicans have had both copies of the candidate gene deleted. Most of the mutants were created in biological duplicate. From this collection, 1274 strains corresponding to 653 unique genes were screened. The GRACE Collection provided mutants with one copy of each gene deleted and the other copy placed under the control of a doxycycline-repressible promoter. To assay these strains, we used a medium supplemented with 100 µg/ml doxycycline strains, when rendered them functional null mutants. We screened 2348 mutants from the GRACE Collection, 255 of which overlapped with mutants in the Noble Collection, for 2746 total unique mutants screened in total. To assess the defects in biofilm formation or biofilm-related traits, we performed 2 assays: (1) colony morphology on agar medium and (2) biofilm formation on a plastic surface (Fig. 14). For both of these assays, we used Spider medium, which was designed to induce hyphal growth in C. albicans [57] and which promotes biofilm formation [39]. Strains were first replicated from frozen 96-well plates to YPD agar plates. Strains were then replicated from YPD agar to YPD broth and grown overnight at 30 ∘C. From YPD broth, strains were introduced onto Spider agar plates and into 96-well plates of Spider broth. When strains from the GRACE Collection were assayed, 100 µg/ml doxycycline was included in the agar and broth, and aluminum foil was used to protect the media from light. Spider agar plates inoculated with C. albicans mutants were incubated at 37 ∘C for 2 days before colony morphologies were scored. Strains in Spider broth were shaken at 225 rpm at 37 ∘C for 3 days and then assayed for biofilm formation at the air-liquid interface as follows. First, broth was removed by slowly tilting the plates and pulling the liquid away by running a gloved hand over the surface. Biofilms were stained by adding 100 µl of 0.1 percent crystal violet dye in water to each well of the plate. After 15 min, plates were gently washed in three baths of water to remove dye without disturbing biofilms. To score biofilm formation for agar plates, colonies were scored by eye as either smooth, intermediate, or wrinkled. A wild-type colony would score wrinkled, and mutants with intermediate or smooth appearance were considered defective in colony biofilm formation. For biofilm formation on a plastic surface, the presence of a ring of cell material in the well indicated normal biofilm formation, while low or no ring formation mutants were considered defective. Genes whose mutations resulted defects in both or either assay were considered true for biofilm function. A complete list of the mutants identified in the screens is available in Additional file 1: Table S1.

Fig. 14
figure14

a: different phenotypes in response to doxycycline treatment: low growth, smooth, no growth and intermediate. b: adherence phenotypes. See text for details

Full size image

A protein is considered true in the biofilm function, if its mutant phenotype is smooth or intermediate under doxycycline.

Term-centric evaluation

The evaluations of the CAFA- π methods were based on the experimental results in the “Microbe screens” section. We adopted Fmax based on both precision-recall curves and area under ROC curves. There are a total of six baseline methods, as described in Table 3.

Discussion

Since 2010, the CAFA community has been the home to a growing group of scientists across the globe sharing the goal of improving computational function prediction. CAFA has been advancing this goal in three ways. First, through independent evaluation of computational methods against the set of benchmark proteins, thus providing a direct comparison of the methods’ reliability and performance at a given time point. Second, the challenge assesses the quality of the current state of the annotations, whether they are made computationally or not, and is set up to reliably track it over time. Finally, as described in this work, CAFA has started to drive the creation of new experimental annotations by facilitating synergies between different groups of researchers interested in function of biological macromolecules. These annotations not only represent new biological discoveries, but simultaneously serve to provide benchmark data for rigorous method evaluation.

CAFA3 and CAFA- π feature the latest advances in the CAFA series to create advanced and accurate methods for protein function prediction. We use the repeated nature of the CAFA project to identify certain trends via historical assessments. The analysis revealed that the performance of CAFA methods improved dramatically between CAFA1 and CAFA2. However, the protein-centric results for CAFA3 are mixed when compared to historical methods. Though the best-performing CAFA3 method outperformed the top CAFA2 methods (Fig. 1), this was not consistently true for other rankings. Among all 3 CAFA challenges, CAFA2 and CAFA3 methods inhabit the top 12 places in MFO and BPO. Between CAFA2 and CAFA3, the performance increase is more subtle. Based on the annotations of methods (Additional file 1), many of the top-ranking methods are improved versions of the methods that have been evaluated in CAFA2. Interestingly, the top-performing CAFA3 method, which consistently outperformed the methods from all past CAFAs in the major categories (GOLabeler [23]), utilized 5 component classifiers trained from different features; those included GO term frequency, sequence alignment, amino acid trigram, domains, motifs, and biophysical properties. It performs best in the Molecular Function Ontology, where sequence features perform best. Another method which did not participate in CAFA3 yet seems to perform well under CAFA parameters is NetGO [58], which utilizes the information from STRING, a network association database [59] in addition to sequence information. Taken together, the strong predictive performance of mRNA co-expression data (Figs. 9 and 15) leads us to hypothesize that including more varied sources of data can lead to additional large improvements in protein function prediction. We are looking forward to testing this hypothesis in future CAFA challenges. It should be noted that CAFA uses both Fmax and Smin. Fmax’s strength lies in its interpretability, as it is simply the maximum F1 given for each model. At the same time, precision/recall-based assessment does not capture the hierarchical nature of ontologies or the differences in information content between different GO terms. For that reason, we also use the Smin score which incorporates information content, but is somewhat less interpretable than Fmax and less robust to the problems of incomplete annotation [60, 61]. Additionally, since the information content of a GO term is derived from its frequency in the corpus [62], it is somewhat malleable depending on the corpus from which it is derived. We therefore use both measures for scoring, to achieve a more comprehensive picture of the models’ performance.

Fig. 15
figure15

AUROC of top 5 teams in CAFA- π. The best-performing model from each team is picked for the top five teams, regardless of whether that model is submitted as model 1. All team methods are in gray while BLAST methods are in red, BLAST computational methods are in blue and expression are in yellow. See Table 3 for description of the baselines

Full size image

For this iteration of CAFA, we performed genome-wide screens of phenotypes in P. aeruginosa and C. albicans as well as a targeted screen in D. melanogaster. This not only allowed us to assess the accuracy with which methods predict genes associated with select biological processes, but also to use CAFA as an additional driver for new biological discovery. Note that high-throughput screening for a single phenotype should be interpreted with caution as the phenotypic effect may be the result of pleiotropy, and the phenotype in question may be expressed as part of a set of other phenotypes. The results of genome-wide screenings typically lack context for the observed phenotypic effects, and each genotype-phenotype association should be examined individually to ascertain how immediate is the phenotypic effect from the seeming genotypic cause.

In sum, our experimental work identified more than a thousand new functional annotations in three highly divergent species. Though all screens have certain limitations, the genome-wide screens also bypass questions of biases in curation. This evaluation provides key insights: CAFA3 methods did not generalize well to selected terms. Because of that, we ran a second effort, CAFA- π, in which participants focused solely on predicting the results of these targeted assays. This targeted effort led to improved performance, suggesting that when the goal is to identify genes associated with a specific phenotype, tuning methods may be required.

For CAFA evaluations, we have included both Naïve and sequence-based (BLAST) baseline methods. For the evaluation of P. aeruginosa screen results, we were also able to include a gene expression baseline from a previously published compendium [33]. Intriguingly, the expression-based predictions outperformed the existing methods for this task. In future CAFA efforts, we will include this type of baseline expression-based method across evaluations to continue to assess the extent to which this data modality informs gene function prediction. The results from the CAFA3 effort suggest that gene expression may be particularly important for successfully predicting term-centric biological process annotations.

The primary takeaways from CAFA3 are as follows: (1) genome-wide screens complement annotation-based efforts to provide a richer picture of protein function prediction; (2) the best-performing method was a new method, instead of a light retooling of an existing approach; (3) gene expression, and more broadly, systems data may provide key information to unlocking biological process predictions, and (4) performance of the best methods has continued to improve. The results of the screens released as part of CAFA3 can lead to a re-examination of approaches which we hope will lead to improved performance in CAFA4.

References

  1. 1

    Goodwin S, McPherson JD, McCombie WR. Coming of age: ten years of next-generation sequencing technologies. Nat Rev Genet. 2016; 17(6):333–51.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  2. 2

    Aebersold R, Mann M. Mass spectrometry-based proteomics. Nature. 2003; 422(6928):198–207.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  3. 3

    Schnoes AM, Ream DC, Thorman AW, Babbitt PC, Friedberg I. Biases in the experimental annotations of protein function and their effect on our understanding of protein function space. PLoS Comput Biol. 2013; 9(5):1003063.

    Article  CAS  Google Scholar 

  4. 4

    Rost B, Liu J, Nair R, Wrzeszczynski KO, Ofran Y. Automatic prediction of protein function. Cell Mol Life Sci. 2003; 60(12):2637–50.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  5. 5

    Friedberg I. Automated protein function prediction–the genomic challenge. Brief Bioinform. 2006; 7(3):225–42.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  6. 6

    Sharan R, Ulitsky I, Shamir R. Network-based prediction of protein function. Mol Syst Biol. 2007; 3:88.

    PubMed  PubMed Central  Article  Google Scholar 

  7. 7

    Rentzsch R, Orengo CA. Protein function prediction–the power of multiplicity. Trends Biotechnol. 2009; 27(4):210–9.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  8. 8

    Shehu A, Barbara D, Molloy K. A survey of computational methods for protein function predictions. Cham: Springer; 2016, pp. 225–98.

    Google Scholar 

  9. 9

    Cozzetto D, Jones DT. Computational methods for annotation transfers from sequence. Methods Mol Biol. 2017; 1446:55–67.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  10. 10

    Pellegrini M, Marcotte EM, Thompson MJ, Eisenberg D, Yeates TO. Assigning protein functions by comparative genome analysis: protein phylogenetic profiles. Proc Natl Acad Sci USA. 1999; 96(8):4285–8.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  11. 11

    Jensen LJ, Gupta R, Blom N, Devos D, Tamames J, Kesmir C, Nielsen H, Staerfeldt HH, Rapacki K, Workman C, Andersen CA, Knudsen S, Krogh A, Valencia A, Brunak S. Prediction of human protein function from post-translational modifications and localization features. J Mol Biol. 2002; 319(5):1257–65.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  12. 12

    Deng M, Zhang K, Mehta S, Chen T, Sun F. Prediction of protein function using protein-protein interaction data. J Comput Biol. 2003; 10(6):947–60.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  13. 13

    Pazos F, Sternberg MJ. Automated prediction of protein function and detection of functional sites from structure. Proc Natl Acad Sci USA. 2004; 101(41):14754–9.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  14. 14

    Nabieva E, Jim K, Agarwal A, Chazelle B, Singh M. Whole-proteome prediction of protein function via graph-theoretic analysis of interaction maps. Bioinformatics. 2005; 21(21 Suppl 1):302–10.

    Article  Google Scholar 

  15. 15

    Engelhardt BE, Jordan MI, Muratore KE, Brenner SE. Protein molecular function prediction by Bayesian phylogenomics. PLoS Comput Biol. 2005; 1(5):45.

    Article  CAS  Google Scholar 

  16. 16

    Enault F, Suhre K, Claverie JM. Phydbac “Gene Function Predictor”: a gene annotation tool based on genomic context analysis. BMC Bioinformatics. 2005; 6:247.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  17. 17

    Hawkins T, Luban S, Kihara D. Enhanced automated function prediction using distantly related sequences and contextual association by PFP. Protein Sci. 2006; 15(6):1550–6.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  18. 18

    Wass MN, Sternberg MJ. Confunc–functional annotation in the twilight zone. Bioinformatics. 2008; 24(6):798–806.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  19. 19

    Mostafavi S, Ray D, Warde-Farley D, Grouios C, Morris Q. GeneMANIA: a real-time multiple association network integration algorithm for predicting gene function. Genome Biol. 2008; 9(Suppl 1):4.

    Article  CAS  Google Scholar 

  20. 20

    Sokolov A, Ben-Hur A. Hierarchical classification of gene ontology terms using the GOstruct method. J Bioinform Comput Biol. 2010; 8(2):357–76.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  21. 21

    Clark WT, Radivojac P. Analysis of protein function and its prediction from amino acid sequence. Proteins. 2011; 79(7):2086–96.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  22. 22

    Piovesan D, Tosatto SCE. INGA 2.0: improving protein function prediction for the dark proteome. Nucleic Acids Res. 2019; 47(W1):373–8. https://doi.org/10.1093/nar/gkz375.

    Article  Google Scholar 

  23. 23

    You R, Zhang Z, Xiong Y, Sun F, Mamitsuka H, Zhu S. GOLabeler: improving sequence-based large-scale protein function prediction by learning to rank. Bioinformatics. 2018; 34(14):2465–73.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  24. 24

    Fa R, Cozzetto D, Wan C, Jones DT. Predicting human protein function with multi-task deep neural networks. PLoS One. 2018; 13(6):0198216.

    Article  CAS  Google Scholar 

  25. 25

    Radivojac P, Clark WT, Oron TR, Schnoes AM, Wittkop T, Sokolov A, Graim K, Funk C, Verspoor K, Ben-Hur A, Pandey G, Yunes JM, Talwalkar AS, Repo S, Souza ML, Piovesan D, Casadio R, Wang Z, Cheng J, Fang H, Gough J, Koskinen P, Toronen P, Nokso-Koivisto J, Holm L, Cozzetto D, Buchan DW, Bryson K, Jones DT, Limaye B, et al. A large-scale evaluation of computational protein function prediction. Nat Methods. 2013; 10(3):221–7.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  26. 26

    Jiang Y, Oron TR, Clark WT, Bankapur AR, D’Andrea D, Lepore R, Funk CS, Kahanda I, Verspoor KM, Ben-Hur A, Koo da CE, Penfold-Brown D, Shasha D, Youngs N, Bonneau R, Lin A, Sahraeian SM, Martelli PL, Profiti G, Casadio R, Cao R, Zhong Z, Cheng J, Altenhoff A, Skunca N, Dessimoz C, Dogan T, Hakala K, Kaewphan S, Mehryary F, et al. An expanded evaluation of protein function prediction methods shows an improvement in accuracy. Genome Biol. 2016; 17(1):184.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  27. 27

    Friedberg I, Radivojac P. Community-wide evaluation of computational function prediction. Methods Mol Biol. 2017; 1446:133–46.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  28. 28

    Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT, Harris MA, Hill DP, Issel-Tarver L, Kasarskis A, Lewis S, Matese JC, Richardson JE, Ringwald M, Rubin GM, Sherlock G. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet. 2000; 25(1):25–9.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  29. 29

    Kacsoh BZ, Barton S, Jiang Y, Zhou N, Mooney SD, Friedberg I, Radivojac P, Greene CS, Bosco G. New Drosophila long-term memory genes revealed by assessing computational function prediction methods. G3. 2019; 9(1):251–67.

    PubMed  Article  PubMed Central  Google Scholar 

  30. 30

    Huntley RP, Sawford T, Mutowo-Meullenet P, Shypitsyna A, Bonilla C, Martin MJ, O’Donovan C. The GOA database: gene ontology annotation updates for 2015. Nucleic Acids Res. 2015; 43(Database issue):1057–63.

    Article  CAS  Google Scholar 

  31. 31

    Peng Y, Jiang Y, Radivojac P. Enumerating consistent sub-graphs of directed acyclic graphs: an insight into biomedical ontologies. Bioinformatics. 2018; 34(13):313–22.

    Article  CAS  Google Scholar 

  32. 32

    Wang L, Law J, Kale SD, Murali TM, Pandey G. Large-scale protein function prediction using heterogeneous ensembles. F1000Res. 2018;7.

    CAS  Article  Google Scholar 

  33. 33

    Tan J, Doing G, Lewis KA, Price CE, Chen KM, Cady KC, Perchuk B, Laub MT, Hogan DA, Greene CS. Unsupervised extraction of stable expression signatures from public compendia with an ensemble of neural networks. Cell Syst. 2017; 5(1):63–71.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  34. 34

    Skrzypek MS, Binkley J, Binkley G, Miyasato SR, Simison M, Sherlock G. The Candida Genome Database (CGD): incorporation of Assembly 22, systematic identifiers and visualization of high throughput sequencing data. Nucleic Acids Res. 2017; 45(Database issue):592–6.

    Article  CAS  Google Scholar 

  35. 35

    Goyard S, Knechtle P, Chauvel M, Mallet A, Prevost MC, Proux C, Coppee JY, Schwarz P, Dromer F, Park H, Filler SG, Janbon G, d’Enfert C. The Yak1 kinase is involved in the initiation and maintenance of hyphal growth in Candida albicans. Mol Biol Cell. 2008; 19(5):2251–66.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  36. 36

    Gutierrez-Escribano P, Gonzalez-Novo A, Suarez MB, Li CR, Wang Y, de Aldana CR, Correa-Bordes J. CDK-dependent phosphorylation of Mob2 is essential for hyphal development in Candida albicans. Mol Biol Cell. 2011; 22(14):2458–69.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  37. 37

    Lassak T, Schneider E, Bussmann M, Kurtz D, Manak JR, Srikantha T, Soll DR, Ernst JF. Target specificity of the Candida albicans Efg1 regulator. Mol Microbiol. 2011; 82(3):602–18.

    CAS  PubMed  Article  Google Scholar 

  38. 38

    Martin R, Moran GP, Jacobsen ID, Heyken A, Domey J, Sullivan DJ, Kurzai O, Hube B. The Candida albicans-specific gene EED1 encodes a key regulator of hyphal extension. PLoS One. 2011; 6(4):18394.

    Article  CAS  Google Scholar 

  39. 39

    Richard ML, Nobile CJ, Bruno VM, Mitchell AP. Candida albicans biofilm-defective mutants. Eukaryot Cell. 2005; 4(8):1493–502.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  40. 40

    Bernardo SM, Khalique Z, Kot J, Jones JK, Lee SA. Candida albicans VPS1 contributes to protease secretion, filamentation, and biofilm formation. Fungal Genet Biol. 2008; 45(6):861–77.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  41. 41

    Yi S, Sahni N, Daniels KJ, Lu KL, Huang G, Srikantha T, Soll DR. Self-induction of a/a or α/ α biofilms in Candida albicans is a pheromone-based paracrine system requiring switching. Eukaryot Cell. 2011; 10(6):753–60.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  42. 42

    Hess DC, Myers CL, Huttenhower C, Hibbs MA, Hayes AP, Paw J, Clore JJ, Mendoza RM, Luis BS, Nislow C, Giaever G, Costanzo M, Troyanskaya OG, Caudy AA. Computationally driven, quantitative experiments discover genes required for mitochondrial biogenesis. PLOS Genetics. 2009; 5(3):1–16. https://doi.org/10.1371/journal.pgen.1000407.

    Article  CAS  Google Scholar 

  43. 43

    Hibbs MA, Myers CL, Huttenhower C, Hess DC, Li K, Caudy AA, Troyanskaya OG. Directing experimental biology: a case study in mitochondrial biogenesis. PLOS Comput Biol. 2009; 5(3):1–12. https://doi.org/10.1371/journal.pcbi.1000322.

    Article  CAS  Google Scholar 

  44. 44

    Blus-Kadosh I, Zilka A, Yerushalmi G, Banin E. The effect of pstS and phoB on quorum sensing and swarming motility in Pseudomonas aeruginosa. PLoS One. 2013; 8(9):74444.

    Article  CAS  Google Scholar 

  45. 45

    Kuchma SL, Brothers KM, Merritt JH, Liberati NT, Ausubel FM, O’Toole GA. BifA, a cyclic-Di-GMP phosphodiesterase, inversely regulates biofilm formation and swarming motility by Pseudomonas aeruginosa PA14. J Bacteriol. 2007; 189(22):8165–78.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  46. 46

    Winsor GL, Griffiths EJ, Lo R, Dhillon BK, Shay JA, Brinkman FS. Enhanced annotations and features for comparing thousands of Pseudomonas genomes in the Pseudomonas Genome Database. Nucleic Acids Res. 2016; 44(D1):646–53.

    Article  CAS  Google Scholar 

  47. 47

    Friedman L, Kolter R. Genes involved in matrix formation in Pseudomonas aeruginosa PA14 biofilms. Mol Microbiol. 2004; 51(3):675–90.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  48. 48

    Friedman L, Kolter R. Two genetic loci produce distinct carbohydrate-rich structural components of the Pseudomonas aeruginosa biofilm matrix. J Bacteriol. 2004; 186(14):4457–65.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  49. 49

    Jackson KD, Starkey M, Kremer S, Parsek MR, Wozniak DJ. Identification of psl, a locus encoding a potential exopolysaccharide that is essential for Pseudomonas aeruginosa PAO1 biofilm formation. J Bacteriol. 2004; 186(14):4466–75.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  50. 50

    Synapse. https://www.synapse.org/. Accessed 1 Jan 2016.

  51. 51

    Clark WT, Radivojac P. Information-theoretic evaluation of predicted ontological annotations. Bioinformatics. 2013; 29(13):53–61.

    Article  CAS  Google Scholar 

  52. 52

    Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, Miller W, Lipman DJ. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 1997; 25(17):3389–402.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  53. 53

    Consortium TU. UniProt: the universal protein knowledgebase. Nucleic Acids Res. 2017; 45(D1):158–69.

    Article  CAS  Google Scholar 

  54. 54

    Liberati NT, Urbach JM, Miyata S, Lee DG, Drenkard E, Wu G, Villanueva J, Wei T, Ausubel FM. An ordered, nonredundant library of Pseudomonas aeruginosa strain PA14 transposon insertion mutants. Proc Natl Acad Sci USA. 2006; 103(8):2833–8.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  55. 55

    Noble SM, French S, Kohn LA, Chen V, Johnson AD. Systematic screens of a Candida albicans homozygous deletion library decouple morphogenetic switching and pathogenicity. Nat Genet. 2010; 42(7):590–8.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  56. 56

    Roemer T, Jiang B, Davison J, Ketela T, Veillette K, Breton A, Tandia F, Linteau A, Sillaots S, Marta C, Martel N, Veronneau S, Lemieux S, Kauffman S, Becker J, Storms R, Boone C, Bussey H. Large-scale essential gene identification in Candida albicans and applications to antifungal drug discovery. Mol Microbiol. 2003; 50(1):167–81.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  57. 57

    Liu H, Kohler J, Fink GR. Suppression of hyphal formation in Candida albicans by mutation of a STE12 homolog. Science. 1994; 266(5191):1723–6.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  58. 58

    You R, Yao S, Xiong Y, Huang X, Sun F, Mamitsuka H, Zhu S. NetGO: improving large-scale protein function prediction with massive network information. Nucleic Acids Res. 2019; 47(W1):379–87. https://doi.org/10.1093/nar/gkz388.

    Article  Google Scholar 

  59. 59

    Szklarczyk D, Franceschini A, Wyder S, Forslund K, Heller D, Huerta-Cepas J, Simonovic M, Roth A, Santos A, Tsafou KP, Kuhn M, Bork P, Jensen LJ, von Mering C. STRING v10: protein-protein interaction networks, integrated over the tree of life. Nucleic Acids Res. 2015; 43(Database issue):447–52. https://doi.org/10.1093/nar/gku1003.

    Article  CAS  Google Scholar 

  60. 60

    Dessimoz C, Skunca N, Thomas PD. CAFA and the open world of protein function predictions. Trends Genet. 2013; 29(11):609–10.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  61. 61

    Jiang Y, Clark WT, Friedberg I, Radivojac P. The impact of incomplete knowledge on the evaluation of protein function prediction: a structured-output learning perspective. Bioinformatics. 2014; 30(17):609–16.

    Article  CAS  Google Scholar 

  62. 62

    Lord PW, Stevens RD, Brass A, Goble CA. Investigating semantic similarity measures across the Gene Ontology: the relationship between sequence and annotation. Bioinformatics. 2003; 19(10):1275–83. https://doi.org/10.1093/bioinformatics/btg153. Accessed 1 Aug 2019.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  63. 63

    Zhou N. Supplementary data. figshare. 2019. https://doi.org/10.6084/m9.figshare.8135393.v3. https://figshare.com/articles/Supplementary_data/8135393/3.

  64. 64

    Jiang Y. CAFA2. Zenodo. 2019. https://doi.org/10.5281/zenodo.3403452.

  65. 65

    Zhou N, Gerten M, Friedberg I. CAFA_assessment_tool. Zenodo. 2019. https://doi.org/10.5281/zenodo.3401694.

Download references

Acknowledgements

NZ and IF acknowledge the invaluable input from Michael C Gerten and Shatabdi Sen and all members of the Friedberg Lab for the ongoing support for stimulating discussions.

Review history

The review history is available as Additional file 2.

Funding

The work of IF was funded, in part, by the National Science Foundation award DBI-1458359. The work of CSG and AJL was funded, in part, by the National Science Foundation award DBI-1458390 and GBMF 4552 from the Gordon and Betty Moore Foundation. The work of DAH and KAL was funded, in part, by the National Science Foundation award DBI-1458390, National Institutes of Health NIGMS P20 GM113132, and the Cystic Fibrosis Foundation CFRDP STANTO19R0. The work of AP, HY, AR, and MT was funded by BBSRC grants BB/K004131/1, BB/F00964X/1 and BB/M025047/1, Consejo Nacional de Ciencia y Tecnología Paraguay (CONACyT) grants 14-INV-088 and PINV15-315, and NSF Advances in BioInformatics grant 1660648. The work of JC was partially supported by an NIH grant (R01GM093123) and two NSF grants (DBI 1759934 and IIS1763246). ACM acknowledges the support by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) under Germany’s Excellence Strategy - EXC 2155 “RESIST” - Project ID 39087428. DK acknowledges the support from the National Institutes of Health (R01GM123055) and the National Science Foundation (DMS1614777, CMMI1825941). PB acknowledges the support from the National Institutes of Health (R01GM60595). GB and BZK acknowledge the support from the National Science Foundation (NSF 1458390) and NIH DP1MH110234. FS was funded by the ERC StG 757700 “HYPER-INSIGHT” and by the Spanish Ministry of Science, Innovation and Universities grant BFU2017-89833-P. FS further acknowledges the funding from the Severo Ochoa award to the IRB Barcelona. TS was funded by the Centre of Excellence project “BioProspecting of Adriatic Sea”, co-financed by the Croatian Government and the European Regional Development Fund (KK.01.1.1.01.0002). The work of SK was funded by ATT Tieto käyttöön grant and Academy of Finland. JB and HM acknowledge the support of the University of Turku, the Academy of Finland and CSC – IT Center for Science Ltd. TB and SM were funded by the NIH awards UL1 TR002319 and U24 TR002306. The work of CZ and ZW was funded by the National Institutes of Health R15GM120650 to ZW and start-up funding from the University of Miami to ZW. The work of PWR was supported by the National Cancer Institute of the National Institutes of Health under Award Number U01CA198942. PR acknowledges NSF grant DBI-1458477. PT acknowledges the support from Helsinki Institute for Life Sciences. The work of AJM was funded by the Academy of Finland (No. 292589). The work of FZ and WT was funded by the National Natural Science Foundation of China (31671367, 31471245, 91631301) and the National Key Research and Development Program of China (2016YFC1000505, 2017YFC0908402]. CS acknowledges the support by the Italian Ministry of Education, University and Research (MIUR) PRIN 2017 project 2017483NH8. SZ is supported by the National Natural Science Foundation of China (No. 61872094 and No. 61572139) and Shanghai Municipal Science and Technology Major Project (No. 2017SHZDZX01). PLF and RLH were supported by the National Institutes of Health NIH R35-GM128637 and R00-GM097033. JG, DTJ, CW, DC, and RF were supported by the UK Biotechnology and Biological Sciences Research Council (BB/N019431/1, BB/L020505/1, and BB/L002817/1) and Elsevier. The work of YZ and CZ was funded in part by the National Institutes of Health award GM083107, GM116960, and AI134678; the National Science Foundation award DBI1564756; and the Extreme Science and Engineering Discovery Environment (XSEDE) award MCB160101 and MCB160124. The work of BG, VP, RD, NS, and NV was funded by the Ministry of Education, Science and Technological Development of the Republic of Serbia, Project No. 173001. The work of YWL, WHL, and JMC was funded by the Taiwan Ministry of Science and Technology (106-2221-E-004-011-MY2). YWL, WHL, and JMC further acknowledge the support from “the Human Project from Mind, Brain and Learning” of the NCCU Higher Education Sprout Project by the Taiwan Ministry of Education and the National Center for High-performance Computing for computer time and facilities. The work of IK and AB was funded by Montana State University and NSF Advances in Biological Informatics program through grant number 0965768. BR, TG, and JR are supported by the Bavarian Ministry for Education through funding to the TUM. The work of RB, VG, MB, and DCEK was supported by the Simons Foundation, NIH NINDS grant number 1R21NS103831-01 and NSF award number DMR-1420073. CJJ acknowledges the funding from a University of Illinois at Chicago (UIC) Cancer Center award, a UIC College of Liberal Arts and Sciences Faculty Award, and a UIC International Development Award. The work of ML was funded by Yad Hanadiv (grant number 9660 /2019). The work of OL and IN was funded by the National Institute of General Medical Science of the National Institute of Health through GM066099 and GM079656. Research Supporting Plan (PSR) of University of Milan number PSR2018-DIP-010-MFRAS. AWV acknowledges the funding from the BBSRC (CASE studentship BB/M015009/1). CD acknowledges the support from the Swiss National Science Foundation (150654). CO and MJM are supported by the EMBL-European Bioinformatics Institute core funds and the CAFA BBSRC BB/N004876/1. GG is supported by CAFA BBSRC BB/N004876/1. SCET acknowledges funding from the European Union’s Horizon 2020 research and innovation program under the Marie Sklodowska-Curie grant agreement No 778247 (IDPfun) and from COST Action BM1405 (NGP-net). SEB was supported by NIH/NIGMS grant R01 GM071749. The work of MLT, JMR, and JMF was supported by the National Human Genome Research Institute of the National of Health, grant numbers U41 HG007234. The work of JMF and JMR was also supported by INB Grant (PT17/0009/0001 - ISCIII-SGEFI / ERDF). VA acknowledges the funding from TUBITAK EEEAG-116E930. RCA acknowledges the funding from KanSil 2016K121540. GV acknowledges the funding from Università degli Studi di Milano - Project “Discovering Patterns in Multi-Dimensional Data” and Project “Machine Learning and Big Data Analysis for Bioinformatics”. SZ is supported by the National Natural Science Foundation of China (No. 61872094 and No. 61572139) and Shanghai Municipal Science and Technology Major Project (No. 2017SHZDZX01). RY and SY are supported by the 111 Project (NO. B18015), the key project of Shanghai Science & Technology (No. 16JC1420402), Shanghai Municipal Science and Technology Major Project (No. 2018SHZDZX01), and ZJLab. ST was supported by project Ribes Network POR-FESR 3S4H (No. TOPP-ALFREVE18-01) and PRID/SID of University of Padova (No. TOPP-SID19-01). CZ and ZW were supported by the NIGMS grant R15GM120650 to ZW and start-up funding from the University of Miami to ZW. The work of MK and RH was supported by the funding from King Abdullah University of Science and Technology (KAUST) Office of Sponsored Research (OSR) under Award No. URF/1/3454-01-01 and URF/1/3790-01-01. The work of SDM is funded, in part, by NSF award DBI-1458443.

Author information

Affiliations

  1. Veterinary Microbiology and Preventive Medicine, Iowa State University, Ames, IA, USA

    Naihui Zhou, Huy N. Nguyen, Md Nafiz Hamid & Iddo Friedberg

  2. Program in Bioinformatics and Computational Biology, Ames, IA, USA

    Naihui Zhou, Md Nafiz Hamid & Larry Davis

  3. Indiana University Bloomington, Bloomington, Indiana, USA

    Yuxiang Jiang

  4. Department of Biomedical Informatics and Medical Education, University of Washington, Seattle, WA, USA

    Timothy R. Bergquist & Sean D. Mooney

  5. Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Philadelphia, PA, USA

    Alexandra J. Lee

  6. Geisel School of Medicine at Dartmouth, Hanover, NH, USA

    Balint Z. Kacsoh & Deborah A. Hogan

  7. Department of Molecular and Systems Biology, Hanover, NH, USA

    Balint Z. Kacsoh

  8. Department of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Hanover, NH, USA

    Alex W. Crocker, Kimberley A. Lewis & Deborah A. Hogan

  9. European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Hinxton, United Kingdom

    George Georghiou, Maria J. Martin & Claire O’Donovan

  10. Program in Computer Science, Ames, IA, USA

    Huy N. Nguyen

  11. Department of Computer Engineering, Hacettepe University, Ankara, Turkey

    Tunca Dogan

  12. Department of Computer Engineering, Middle East Technical University (METU), Ankara, Turkey

    Volkan Atalay, Ahmet S. Rifaioglu & Alperen Dalkıran

  13. Department of Computer Engineering, Iskenderun Technical University, Hatay, Turkey

    Ahmet S. Rifaioglu

  14. CanSyL, Graduate School of Informatics, Middle East Technical University, Ankara, Turkey

    Rengul Cetin Atalay

  15. Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI, USA

    Chengxin Zhang, Peter L. Freddolino & Yang Zhang

  16. Department of Biological Chemistry, University of Michigan, Ann Arbor, MI, USA

    Rebecca L. Hurto, Peter L. Freddolino & Yang Zhang

  17. Achira Labs, Bangalore, India

    Prajwal Bhat

  18. Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain

    Fran Supek

  19. Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain

    Fran Supek

  20. INB Coordination Unit, Life Sciences Department, Barcelona Supercomputing Center, Barcelona, Catalonia, Spain

    José M. Fernández

  21. (former) INB GN2, Structural and Computational Biology Programme, Spanish National Cancer Research Centre, Barcelona, Catalonia, Spain

    José M. Fernández

  22. Laboratory for Bioinformatics and Computational Chemistry, Institute of Nuclear Sciences VINCA, University of Belgrade, Belgrade, Serbia

    Branislava Gemovic, Vladimir R. Perovic, Radoslav S. Davidović, Neven Sumonja & Nevena Veljkovic

  23. Molecular Cell Biomechanics Laboratory, Departments of Bioengineering, University of California Berkeley, Berkeley, CA, USA

    Ehsaneddin Asgari

  24. Computational Biology of Infection Research, Helmholtz Centre for Infection Research, Berkeley, CA, USA

    Ehsaneddin Asgari

  25. Departments of Bioengineering and Mechanical Engineering, Berkeley, CA, USA

    Mohammad R.K. Mofrad

  26. Bologna Biocomputing Group, Department of Pharmacy and Biotechnology, University of Bologna, Bologna, Italy

    Giuseppe Profiti, Castrense Savojardo, Pier Luigi Martelli & Rita Casadio

  27. National Research Council, IBIOM, Bologna, Italy

    Giuseppe Profiti

  28. University of Bonn: INRES Crop Bioinformatics, Bonn, North Rhine-Westphalia, Germany

    Florian Boecker

  29. INRES Crop Bioinformatics, University of Bonn, Bonn, Germany

    Heiko Schoof

  30. Gianforte School of Computing, Montana State University, Bozeman, Montana, USA

    Indika Kahanda

  31. University of Bristol, Computer Science, Bristol, Bristol, United Kingdom

    Natalie Thurlby

  32. Computational Biology of Infection Research, Helmholtz Centre for Infection Research, Brunswick, Germany

    Alice C. McHardy

  33. RESIST, DFG Cluster of Excellence 2155, Brunswick, Germany

    Alice C. McHardy

  34. Interuniversity Institute of Bioinformatics in Brussels, Université libre de Bruxelles - Vrije Universiteit Brussel, Brussels, Belgium

    Alexandre Renaux

  35. Machine Learning Group, Université libre de Bruxelles, Brussels, Belgium

    Alexandre Renaux

  36. Artificial Intelligence lab, Vrije Universiteit Brussel, Brussels, Belgium

    Alexandre Renaux

  37. European Molecular Biolo gy Labora tory, European Bioinformatics Institute (EMBL-EBI), Cambridge, UK

    Tunca Dogan & Rabie Saidi

  38. MRC Laboratory of Molecular Biology, Cambridge, United Kingdom

    Julian Gough

  39. University of Kent, School of Computing, Canterbury, United Kingdom

    Alex A. Freitas & Fabio Fabris

  40. School of Biosciences, University of Kent, Canterbury, Kent, United Kingdom

    Magdalena Antczak & Mark N. Wass

  41. University of Missouri, Computer Science, Columbia, Missouri, USA

    Jie Hou

  42. Department of Electrical Engineering and Computer Science, University of Missouri, Columbia, MO, USA

    Jie Hou & Jianlin Cheng

  43. University of Miami, Coral Gables, Florida, USA

    Zheng Wang

  44. Centre for Systems and Synthetic Biology, Department of Computer Science, Royal Holloway, University of London, Egham, Surrey, United Kingdom

    Alfonso E. Romero, Alberto Paccanaro & Mateo Torres

  45. School of Mathematics, Statistics and Applied Mathematics, National University of Ireland, Galway, Galway, Ireland

    Haixuan Yang

  46. Technical University of Munich, Garching, Germany

    Haixuan Yang

  47. Faculty for Informatics, Garching, Germany

    Chenguang Zhao

  48. Department for Bioinformatics and Computational Biology, Garching, Germany

    Chenguang Zhao

  49. School of Computing Sciences and Computer Engineering, Hattiesburg, Mississippi, USA

    Chenguang Zhao

  50. Institute of Biotechnology, Helsinki Institute of Life Sciences, University of Helsinki, Finland, Helsinki, Finland

    Liisa Holm, Petri Törönen & Alan J. Medlar

  51. Institute of Biotechnology, University of Helsinki, Helsinki, Finland

    Elaine Zosa

  52. Compugen Ltd., Holon, Israel

    Itamar Borukhov

  53. Baylor College of Medicine, Department of Biochemistry and Molecular Biology, Houston, TX, USA

    Ilya Novikov

  54. Baylor College of Medicine, Department of Molecular and Human Genetics, Houston, TX, USA

    Angela Wilkins & Olivier Lichtarge

  55. National TsingHua University, Hsinchu, Taiwan

    Po-Han Chi

  56. Department of Electrical Engineering in National Tsing Hua University, Hsinchu City, Taiwan

    Wei-Cheng Tseng

  57. The Hebrew University of Jerusalem, Jerusalem, Israel

    Michal Linial

  58. University of California San Diego, San Diego Supercomputer Center, La Jolla, California, USA

    Peter W. Rose

  59. Department of Computational Biology and Center for Integrative Genomics, University of Lausanne, Lausanne, Switzerland

    Christophe Dessimoz

  60. Department of Genetics, Evolution & Environment, and Department of Computer Science, University College London, London, UK

    Christophe Dessimoz

  61. Swiss Institute of Bioinformatics, Lausanne, Switzerland

    Christophe Dessimoz

  62. Department of Knowledge Technologies, Jozef Stefan Institute, Ljubljana, Slovenia

    Vedrana Vidulin

  63. Jozef Stefan Institute, Ljubljana, Slovenia

    Saso Dzeroski

  64. Jozef Stefan International Postgraduate School, Ljubljana, Slovenia

    Saso Dzeroski

  65. Research Department of Structural and Molecular Biology, University College London, London, England

    Ian Sillitoe

  66. Research Department of Structural and Molecular Biology, University College London, London, United Kingdom

    Sayoni Das, Jonathan Gill Lees & Christine A. Orengo

  67. Department of Health and Life Sciences, Oxford Brookes University, London, UK

    Jonathan Gill Lees

  68. Department of Computer Science, University College London, London, United Kingdom

    Cen Wan, Domenico Cozzetto & Rui Fa

  69. The Francis Crick Institute, Biomedical Data Science Laboratory, London, United Kingdom

    David T. Jones, Cen Wan, Domenico Cozzetto & Rui Fa

  70. Department of Genetics, Evolution and Environment, University College London, Gower Street, London, WC1E 6BT, United Kingdom

    David T. Jones & Alex Warwick Vesztrocy

  71. SIB Swiss Institute of Bioinformatics, Lausanne, 1015, Switzerland

    Alex Warwick Vesztrocy

  72. Cardiovascular Proteomics Laboratory, Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Madrid, Spain

    Jose Manuel Rodriguez

  73. Spanish National Cancer Research Centre (CNIO), Madrid, Spain

    Michael L. Tress

  74. Università degli Studi di Milano - Computer Science Department - AnacletoLab, Milan, Milan, Italy

    Marco Frasca, Marco Notaro, Giuliano Grossi, Alessandro Petrini, Matteo Re, Giorgio Valentini & Marco Mesiti

  75. Institut de Biologie Computationnelle, LIRMM, CNRS-UMR 5506, Universite de Montpellier, Montpellier, France

    Marco Mesiti

  76. Department of Informatics, Bioinformatics and Computational Biology—i12, Technische Universitat Munchen, Munich, Germany

    Daniel B. Roche & Jonas Reeb

  77. University of Lorraine, CNRS, Inria, LORIA, Nancy, 54000, France

    David W. Ritchie, Sabeur Aridhi, Seyed Ziaeddin Alborzi & Marie-Dominique Devignes

  78. University of Lorraine, Nancy, Lorraine, France

    Marie-Dominique Devignes

  79. Inria, Nancy, France

    Seyed Ziaeddin Alborzi & Marie-Dominique Devignes

  80. Department of Biology, New York University, New York, NY, USA

    Da Chen Emily Koo

  81. NYU Center for Data Science, New York, 10010, NY, USA

    Richard Bonneau

  82. Flatiron Institute, CCB, New York, 10010, NY, USA

    Richard Bonneau

  83. Center for Computational Biology (CCB), Flatiron Institute, Simons Foundation, New York, New York, USA

    Vladimir Gligorijević

  84. Center for Data Science, New York University, New York, 10011, NY, USA

    Meet Barot

  85. Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK

    Hai Fang

  86. Department of Molecular Medicine, University of Padova, Padova, Italy

    Stefano Toppo, Enrico Lavezzo & Michele Berselli

  87. Department of Biology, University of Padova, Padova, Italy

    Marco Falda

  88. CNR Institute of Neuroscience, Padova, Italy

    Silvio C.E. Tosatto

  89. Department of Biomedical Sciences, University of Padua, Padova, Italy

    Silvio C.E. Tosatto, Marco Carraro & Damiano Piovesan

  90. Department of Computer Science, National University of Computer and Emerging Sciences, Peshawar, Khyber Pakhtoonkhwa, Pakistan

    Hafeez Ur Rehman

  91. Department of Computer and Information Sciences, Temple University, Philadelphia, PA, USA

    Qizhong Mao, Shanshan Zhang & Slobodan Vucetic

  92. University of California, Riverside, Philadelphia, PA, USA

    Qizhong Mao

  93. Department of Biology, Brigham Young University, Provo, UT, USA

    Gage S. Black, Dane Jo, Erica Suh, Jonathan B. Dayton, Dallas J. Larsen & Ashton R. Omdahl

  94. Bioinformatics Research Group, Provo, UT, USA

    Gage S. Black, Dane Jo, Jonathan B. Dayton, Dallas J. Larsen & Ashton R. Omdahl

  95. School of Biological Sciences, University of Reading, Reading, England, United Kingdom

    Liam J. McGuffin & Danielle A. Brackenridge

  96. Department of Pharmaceutical Chemistry, San Francisco, CA, USA

    Patricia C. Babbitt

  97. UC Berkeley - UCSF Graduate Program in Bioengineering, University of California, San Francisco, 94158, CA, USA

    Jeffrey M. Yunes

  98. Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, 94158, CA, USA

    Patricia C. Babbitt & Jeffrey M. Yunes

  99. Research and Innovation Center, Edmund Mach Foundation, San Michele all’Adige, Italy

    Paolo Fontana

  100. State Key Laboratory of Genetic Engineering and Collaborative Innovation Center for Genetics and Development, Fudan University, Shanghai, Shanghai, China

    Feng Zhang

  101. Department of Biostatistics and Computational Biology, School of Life Sciences, Fudan University, Shanghai, Shanghai, China

    Feng Zhang

  102. School of Computer Science and Shanghai Key Lab of Intelligent Information Processing, Fudan University, Shanghai, China

    Shanfeng Zhu, Ronghui You, Zihan Zhang, Suyang Dai & Shuwei Yao

  103. Institute of Science and Technology for Brain-Inspired Intelligence and Shanghai Institute of Artificial Intelligence Algorithms, Fudan University, Shanghai, China

    Shanfeng Zhu, Ronghui You & Shuwei Yao

  104. Key Laboratory of Computational Neuroscience and Brain-Inspired Intelligence (Fudan University), Ministry of Education, Shanghai, China

    Shanfeng Zhu, Ronghui You, Zihan Zhang & Suyang Dai

  105. State Key Laboratory of Genetic Engineering and Collaborative Innovation Center for Genetics and Development, Department of Biostatistics and Computational Biology, School of Life Sciences, Fudan University, Shanghai, Shanghai, China

    Weidong Tian

  106. Department of Pediatrics, Brain Tumor Center, Division of Experimental Hematology and Cancer Biology, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, USA

    Weidong Tian

  107. Department of Computer Science, Pacific Lutheran University, Tacoma, WA, USA

    Renzhi Cao, Caleb Chandler, Miguel Amezola & Devon Johnson

  108. Department of Computer Science, National Chengchi University, Taipei, Taiwan

    Jia-Ming Chang, Wen-Hung Liao & Yi-Wei Liu

  109. Okinawa Institute of Science and Technology, Tancha, Okinawa, Japan

    Stefano Pascarelli

  110. Tel Aviv University, Tel Aviv, Israel

    Yotam Frank

  111. Computer, Electrical and Mathematical Sciences & Engineering Division, Computational Bioscience Research Center, King Abdullah University of Science and Technology, Thuwal, Jeddah, Saudi Arabia

    Robert Hoehndorf & Maxat Kulmanov

  112. Computational Bioscience Research Center (CBRC), King Abdullah University of Science and Technology, Thuwal, Saudi Arabia

    Imane Boudellioua

  113. Computer, Electrical and Mathematical Sciences Engineering Division (CEMSE), King Abdullah University of Science and Technology, Thuwal, Saudi Arabia

    Imane Boudellioua

  114. Control and Computer Engineering Department, Politecnico di Torino, Torino, TO, Italy

    Gianfranco Politano, Stefano Di Carlo & Alfredo Benso

  115. Department of Future Technologies, Turku NLP Group, University of Turku, Turku, Finland

    Kai Hakala, Filip Ginter, Farrokh Mehryary & Suwisa Kaewphan

  116. University of Turku Graduate School (UTUGS), Turku, Finland

    Kai Hakala, Farrokh Mehryary & Suwisa Kaewphan

  117. University of Turku, Turku, Finland

    Filip Ginter & Hans Moen

  118. Turku Centre for Computer Science (TUCS), Turku, Finland

    Suwisa Kaewphan

  119. Department of Future Technologies, Faculty of Science and Engineering, University of Turku, Turku, FI-20014, Finland

    Jari Björne & Tapio Salakoski

  120. Turku Centre for Computer Science (TUCS), Agora, Vesilinnantie 3, Turku, FI-20500, Finland

    Jari Björne & Tapio Salakoski

  121. Department of Future Technologies, University of Turku, Turku, Finland

    Martti E.E. Tolvanen

  122. Department of Biological Sciences, Department of Computer Science, Purdue University, 47907, IN, USA

    Daisuke Kihara

  123. Department of Pediatrics, University of Cincinnati, Cincinnati, 45229, OH, USA

    Daisuke Kihara

  124. Department of Computer Science, Purdue University, West Lafayette, IN, USA

    Aashish Jain

  125. Division of Electronics, Rudjer Boskovic Institute, Zagreb, Croatia

    Tomislav Šmuc

  126. Department of Computer Science, ETH Zurich, Zurich, Switzerland

    Adrian Altenhoff

  127. SIB Swiss Institute of Bioinformatics, Zurich, Switzerland

    Adrian Altenhoff

  128. Department of Computer Science, Colorado State University, Fort Collins, CO, USA

    Asa Ben-Hur

  129. Department of Informatics, Bioinformatics & Computational Biology—i12, Technische Universitat Munchen, Munich, Germany

    Tatyana Goldberg & Burkhard Rost

  130. Institute for Food and Plant Sciences WZW, Technische Universität München, Freising, Germany

    Burkhard Rost

  131. University of California, Berkeley, CA, USA

    Steven E. Brenner

  132. Biological Sciences, University of Illinois at Chicago, Chicago, Illinois, USA

    Constance J. Jeffery

  133. Department of Molecular and Systems Biology, Geisel School of Medicine at Dartmouth, Hanover, NH, USA

    Giovanni Bosco

  134. Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA

    Casey S. Greene

  135. Childhood Cancer Data Lab, Alex’s Lemonade Stand Foundation, Philadelphia, Pennsylvania, USA

    Casey S. Greene

  136. Khoury College of Computer Sciences, Northeastern University, Boston, MA, USA

    Predrag Radivojac

Authors
  1. Naihui Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yuxiang Jiang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Timothy R. Bergquist
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Alexandra J. Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Balint Z. Kacsoh
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Alex W. Crocker
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Kimberley A. Lewis
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. George Georghiou
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Huy N. Nguyen
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Md Nafiz Hamid
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Larry Davis
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Tunca Dogan
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Volkan Atalay
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Ahmet S. Rifaioglu
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Alperen Dalkıran
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. Rengul Cetin Atalay
    View author publications

    You can also search for this author in PubMed Google Scholar

  17. Chengxin Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  18. Rebecca L. Hurto
    View author publications

    You can also search for this author in PubMed Google Scholar

  19. Peter L. Freddolino
    View author publications

    You can also search for this author in PubMed Google Scholar

  20. Yang Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  21. Prajwal Bhat
    View author publications

    You can also search for this author in PubMed Google Scholar

  22. Fran Supek
    View author publications

    You can also search for this author in PubMed Google Scholar

  23. José M. Fernández
    View author publications

    You can also search for this author in PubMed Google Scholar

  24. Branislava Gemovic
    View author publications

    You can also search for this author in PubMed Google Scholar

  25. Vladimir R. Perovic
    View author publications

    You can also search for this author in PubMed Google Scholar

  26. Radoslav S. Davidović
    View author publications

    You can also search for this author in PubMed Google Scholar

  27. Neven Sumonja
    View author publications

    You can also search for this author in PubMed Google Scholar

  28. Nevena Veljkovic
    View author publications

    You can also search for this author in PubMed Google Scholar

  29. Ehsaneddin Asgari
    View author publications

    You can also search for this author in PubMed Google Scholar

  30. Mohammad R.K. Mofrad
    View author publications

    You can also search for this author in PubMed Google Scholar

  31. Giuseppe Profiti
    View author publications

    You can also search for this author in PubMed Google Scholar

  32. Castrense Savojardo
    View author publications

    You can also search for this author in PubMed Google Scholar

  33. Pier Luigi Martelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  34. Rita Casadio
    View author publications

    You can also search for this author in PubMed Google Scholar

  35. Florian Boecker
    View author publications

    You can also search for this author in PubMed Google Scholar

  36. Heiko Schoof
    View author publications

    You can also search for this author in PubMed Google Scholar

  37. Indika Kahanda
    View author publications

    You can also search for this author in PubMed Google Scholar

  38. Natalie Thurlby
    View author publications

    You can also search for this author in PubMed Google Scholar

  39. Alice C. McHardy
    View author publications

    You can also search for this author in PubMed Google Scholar

  40. Alexandre Renaux
    View author publications

    You can also search for this author in PubMed Google Scholar

  41. Rabie Saidi
    View author publications

    You can also search for this author in PubMed Google Scholar

  42. Julian Gough
    View author publications

    You can also search for this author in PubMed Google Scholar

  43. Alex A. Freitas
    View author publications

    You can also search for this author in PubMed Google Scholar

  44. Magdalena Antczak
    View author publications

    You can also search for this author in PubMed Google Scholar

  45. Fabio Fabris
    View author publications

    You can also search for this author in PubMed Google Scholar

  46. Mark N. Wass
    View author publications

    You can also search for this author in PubMed Google Scholar

  47. Jie Hou
    View author publications

    You can also search for this author in PubMed Google Scholar

  48. Jianlin Cheng
    View author publications

    You can also search for this author in PubMed Google Scholar

  49. Zheng Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  50. Alfonso E. Romero
    View author publications

    You can also search for this author in PubMed Google Scholar

  51. Alberto Paccanaro
    View author publications

    You can also search for this author in PubMed Google Scholar

  52. Haixuan Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  53. Tatyana Goldberg
    View author publications

    You can also search for this author in PubMed Google Scholar

  54. Chenguang Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

  55. Liisa Holm
    View author publications

    You can also search for this author in PubMed Google Scholar

  56. Petri Törönen
    View author publications

    You can also search for this author in PubMed Google Scholar

  57. Alan J. Medlar
    View author publications

    You can also search for this author in PubMed Google Scholar

  58. Elaine Zosa
    View author publications

    You can also search for this author in PubMed Google Scholar

  59. Itamar Borukhov
    View author publications

    You can also search for this author in PubMed Google Scholar

  60. Ilya Novikov
    View author publications

    You can also search for this author in PubMed Google Scholar

  61. Angela Wilkins
    View author publications

    You can also search for this author in PubMed Google Scholar

  62. Olivier Lichtarge
    View author publications

    You can also search for this author in PubMed Google Scholar

  63. Po-Han Chi
    View author publications

    You can also search for this author in PubMed Google Scholar

  64. Wei-Cheng Tseng
    View author publications

    You can also search for this author in PubMed Google Scholar

  65. Michal Linial
    View author publications

    You can also search for this author in PubMed Google Scholar

  66. Peter W. Rose
    View author publications

    You can also search for this author in PubMed Google Scholar

  67. Christophe Dessimoz
    View author publications

    You can also search for this author in PubMed Google Scholar

  68. Vedrana Vidulin
    View author publications

    You can also search for this author in PubMed Google Scholar

  69. Saso Dzeroski
    View author publications

    You can also search for this author in PubMed Google Scholar

  70. Ian Sillitoe
    View author publications

    You can also search for this author in PubMed Google Scholar

  71. Sayoni Das
    View author publications

    You can also search for this author in PubMed Google Scholar

  72. Jonathan Gill Lees
    View author publications

    You can also search for this author in PubMed Google Scholar

  73. David T. Jones
    View author publications

    You can also search for this author in PubMed Google Scholar

  74. Cen Wan
    View author publications

    You can also search for this author in PubMed Google Scholar

  75. Domenico Cozzetto
    View author publications

    You can also search for this author in PubMed Google Scholar

  76. Rui Fa
    View author publications

    You can also search for this author in PubMed Google Scholar

  77. Mateo Torres
    View author publications

    You can also search for this author in PubMed Google Scholar

  78. Alex Warwick Vesztrocy
    View author publications

    You can also search for this author in PubMed Google Scholar

  79. Jose Manuel Rodriguez
    View author publications

    You can also search for this author in PubMed Google Scholar

  80. Michael L. Tress
    View author publications

    You can also search for this author in PubMed Google Scholar

  81. Marco Frasca
    View author publications

    You can also search for this author in PubMed Google Scholar

  82. Marco Notaro
    View author publications

    You can also search for this author in PubMed Google Scholar

  83. Giuliano Grossi
    View author publications

    You can also search for this author in PubMed Google Scholar

  84. Alessandro Petrini
    View author publications

    You can also search for this author in PubMed Google Scholar

  85. Matteo Re
    View author publications

    You can also search for this author in PubMed Google Scholar

  86. Giorgio Valentini
    View author publications

    You can also search for this author in PubMed Google Scholar

  87. Marco Mesiti
    View author publications

    You can also search for this author in PubMed Google Scholar

  88. Daniel B. Roche
    View author publications

    You can also search for this author in PubMed Google Scholar

  89. Jonas Reeb
    View author publications

    You can also search for this author in PubMed Google Scholar

  90. David W. Ritchie
    View author publications

    You can also search for this author in PubMed Google Scholar

  91. Sabeur Aridhi
    View author publications

    You can also search for this author in PubMed Google Scholar

  92. Seyed Ziaeddin Alborzi
    View author publications

    You can also search for this author in PubMed Google Scholar

  93. Marie-Dominique Devignes
    View author publications

    You can also search for this author in PubMed Google Scholar

  94. Da Chen Emily Koo
    View author publications

    You can also search for this author in PubMed Google Scholar

  95. Richard Bonneau
    View author publications

    You can also search for this author in PubMed Google Scholar

  96. Vladimir Gligorijević
    View author publications

    You can also search for this author in PubMed Google Scholar

  97. Meet Barot
    View author publications

    You can also search for this author in PubMed Google Scholar

  98. Hai Fang
    View author publications

    You can also search for this author in PubMed Google Scholar

  99. Stefano Toppo
    View author publications

    You can also search for this author in PubMed Google Scholar

  100. Enrico Lavezzo
    View author publications

    You can also search for this author in PubMed Google Scholar

  101. Marco Falda
    View author publications

    You can also search for this author in PubMed Google Scholar

  102. Michele Berselli
    View author publications

    You can also search for this author in PubMed Google Scholar

  103. Silvio C.E. Tosatto
    View author publications

    You can also search for this author in PubMed Google Scholar

  104. Marco Carraro
    View author publications

    You can also search for this author in PubMed Google Scholar

  105. Damiano Piovesan
    View author publications

    You can also search for this author in PubMed Google Scholar

  106. Hafeez Ur Rehman
    View author publications

    You can also search for this author in PubMed Google Scholar

  107. Qizhong Mao
    View author publications

    You can also search for this author in PubMed Google Scholar

  108. Shanshan Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  109. Slobodan Vucetic
    View author publications

    You can also search for this author in PubMed Google Scholar

  110. Gage S. Black
    View author publications

    You can also search for this author in PubMed Google Scholar

  111. Dane Jo
    View author publications

    You can also search for this author in PubMed Google Scholar

  112. Erica Suh
    View author publications

    You can also search for this author in PubMed Google Scholar

  113. Jonathan B. Dayton
    View author publications

    You can also search for this author in PubMed Google Scholar

  114. Dallas J. Larsen
    View author publications

    You can also search for this author in PubMed Google Scholar

  115. Ashton R. Omdahl
    View author publications

    You can also search for this author in PubMed Google Scholar

  116. Liam J. McGuffin
    View author publications

    You can also search for this author in PubMed Google Scholar

  117. Danielle A. Brackenridge
    View author publications

    You can also search for this author in PubMed Google Scholar

  118. Patricia C. Babbitt
    View author publications

    You can also search for this author in PubMed Google Scholar

  119. Jeffrey M. Yunes
    View author publications

    You can also search for this author in PubMed Google Scholar

  120. Paolo Fontana
    View author publications

    You can also search for this author in PubMed Google Scholar

  121. Feng Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  122. Shanfeng Zhu
    View author publications

    You can also search for this author in PubMed Google Scholar

  123. Ronghui You
    View author publications

    You can also search for this author in PubMed Google Scholar

  124. Zihan Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  125. Suyang Dai
    View author publications

    You can also search for this author in PubMed Google Scholar

  126. Shuwei Yao
    View author publications

    You can also search for this author in PubMed Google Scholar

  127. Weidong Tian
    View author publications

    You can also search for this author in PubMed Google Scholar

  128. Renzhi Cao
    View author publications

    You can also search for this author in PubMed Google Scholar

  129. Caleb Chandler
    View author publications

    You can also search for this author in PubMed Google Scholar

  130. Miguel Amezola
    View author publications

    You can also search for this author in PubMed Google Scholar

  131. Devon Johnson
    View author publications

    You can also search for this author in PubMed Google Scholar

  132. Jia-Ming Chang
    View author publications

    You can also search for this author in PubMed Google Scholar

  133. Wen-Hung Liao
    View author publications

    You can also search for this author in PubMed Google Scholar

  134. Yi-Wei Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  135. Stefano Pascarelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  136. Yotam Frank
    View author publications

    You can also search for this author in PubMed Google Scholar

  137. Robert Hoehndorf
    View author publications

    You can also search for this author in PubMed Google Scholar

  138. Maxat Kulmanov
    View author publications

    You can also search for this author in PubMed Google Scholar

  139. Imane Boudellioua
    View author publications

    You can also search for this author in PubMed Google Scholar

  140. Gianfranco Politano
    View author publications

    You can also search for this author in PubMed Google Scholar

  141. Stefano Di Carlo
    View author publications

    You can also search for this author in PubMed Google Scholar

  142. Alfredo Benso
    View author publications

    You can also search for this author in PubMed Google Scholar

  143. Kai Hakala
    View author publications

    You can also search for this author in PubMed Google Scholar

  144. Filip Ginter
    View author publications

    You can also search for this author in PubMed Google Scholar

  145. Farrokh Mehryary
    View author publications

    You can also search for this author in PubMed Google Scholar

  146. Suwisa Kaewphan
    View author publications

    You can also search for this author in PubMed Google Scholar

  147. Jari Björne
    View author publications

    You can also search for this author in PubMed Google Scholar

  148. Hans Moen
    View author publications

    You can also search for this author in PubMed Google Scholar

  149. Martti E.E. Tolvanen
    View author publications

    You can also search for this author in PubMed Google Scholar

  150. Tapio Salakoski
    View author publications

    You can also search for this author in PubMed Google Scholar

  151. Daisuke Kihara
    View author publications

    You can also search for this author in PubMed Google Scholar

  152. Aashish Jain
    View author publications

    You can also search for this author in PubMed Google Scholar

  153. Tomislav Šmuc
    View author publications

    You can also search for this author in PubMed Google Scholar

  154. Adrian Altenhoff
    View author publications

    You can also search for this author in PubMed Google Scholar

  155. Asa Ben-Hur
    View author publications

    You can also search for this author in PubMed Google Scholar

  156. Burkhard Rost
    View author publications

    You can also search for this author in PubMed Google Scholar

  157. Steven E. Brenner
    View author publications

    You can also search for this author in PubMed Google Scholar

  158. Christine A. Orengo
    View author publications

    You can also search for this author in PubMed Google Scholar

  159. Constance J. Jeffery
    View author publications

    You can also search for this author in PubMed Google Scholar

  160. Giovanni Bosco
    View author publications

    You can also search for this author in PubMed Google Scholar

  161. Deborah A. Hogan
    View author publications

    You can also search for this author in PubMed Google Scholar

  162. Maria J. Martin
    View author publications

    You can also search for this author in PubMed Google Scholar

  163. Claire O’Donovan
    View author publications

    You can also search for this author in PubMed Google Scholar

  164. Sean D. Mooney
    View author publications

    You can also search for this author in PubMed Google Scholar

  165. Casey S. Greene
    View author publications

    You can also search for this author in PubMed Google Scholar

  166. Predrag Radivojac
    View author publications

    You can also search for this author in PubMed Google Scholar

  167. Iddo Friedberg
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

The experiment was designed by IF, PR, CSG, SDM, COD, MJM, and NZ. NZ, YJ, MNH, HNN, AJL, and LD performed the computational analyses. NZ, SDM, and TM were responsible for managing the participants’ submissions to the CAFA challenge. KAL, AWC, and DAH performed the experimental work in C. albicans and P. aeruginosa. BZK and GB performed the experimental work in D. melanogaster. CJJ, MJM, COD, and GG provided the novel biocurated data for the benchmarks and incorporated data into UniprotKB. All other co-authors developed the computational function prediction methods participating in the challenge, performed the computational protein function predictions, and submitted the results for analysis in CAFA3. NZ, IF, CSG, DAH, and PR wrote the manuscript. All authors have read and approved the final manuscript.

Corresponding authors

Correspondence to Predrag Radivojac or Iddo Friedberg.

Ethics declarations

Ethics approval and consent to participate

Not applicable

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Additional file 1

Additional figures and tables referenced in the article.

Additional file 2

Review History.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Zhou, N., Jiang, Y., Bergquist, T.R. et al. The CAFA challenge reports improved protein function prediction and new functional annotations for hundreds of genes through experimental screens. Genome Biol 20, 244 (2019). https://doi.org/10.1186/s13059-019-1835-8

Download citation

Keywords

  • Protein function prediction
  • Long-term memory
  • Biofilm
  • Critical assessment
  • Community challenge

Genome Biology

ISSN: 1474-760X

Contact us